Natera: Sheena Jonathan trusts sell 1,500 shares

Q: How many NTRA shares did Sheena Jonathan's trusts sell?

Caraluna 1 Trust and Caraluna 2 Trust sold 1,500 Natera common shares in 12 transactions on October 16, 2026. The sales were made under a Rule 10b5-1 trading plan adopted by director and co-founder Sheena Jonathan on June 11, 2026. The shares were held for trust beneficiaries, and Jonathan disclaims beneficial ownership.

A director reported sales by two trusts under a Rule 10b5-1 plan adopted June 11, 2026; the shares were held for trust beneficiaries.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Natera, Inc. (NTRA) had 1,500 common shares sold in 12 transactions by Caraluna 1 Trust and Caraluna 2 Trust on October 16, 2026. The sales were made under a Rule 10b5-1 trading plan adopted by director and co-founder Sheena Jonathan on June 11, 2026. The shares were held for trust beneficiaries, and Jonathan disclaims beneficial ownership. A separate direct-holdings entry lists 221,314 common shares following the transactions.

Insider Trade Summary 10b5-1

Net Seller: 1,500 shares

Net Sell 13 txns

Insider Sheena Jonathan

Role Director

Sold 1,500 shs ($604K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2, F3}	215	$399.3403	$86K
Sale	Common Stock ^{F1, F4, F3}	280	$401.2871	$112K
Sale	Common Stock ^{F1, F5, F3}	90	$404.2528	$36K
Sale	Common Stock ^{F1, F3}	50	$405.15	$20K
Sale	Common Stock ^{F1, F3}	35	$406.625	$14K
Sale	Common Stock ^{F1, F6, F3}	80	$409.3575	$33K
Sale	Common Stock ^{F1, F7, F3}	142	$398.9536	$57K
Sale	Common Stock ^{F1, F8, F3}	280	$400.6765	$112K
Sale	Common Stock ^{F1, F3}	60	$401.62	$24K
Sale	Common Stock ^{F1, F9, F3}	90	$403.6972	$36K
Sale	Common Stock ^{F1, F10, F3}	80	$406.0563	$32K
Sale	Common Stock ^{F1, F11, F3}	98	$409.3438	$40K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,250 shares (Indirect, by Caraluna 1 Trust); Common Stock — 8,250 shares (Indirect, By Caraluna 2 Trust); Common Stock — 221,314 shares (Direct)

Footnotes (11)

F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.0150 to $399.8500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.8500 to $401.6200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.0000 to $404.4550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.0450 to $409.6700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.8050 to $399.0950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.1500 to $400.8850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.4550 to $404.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.0000 to $406.1000 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $408.7800 to $409.7700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Common shares sold: 1,500 shares Reported sale transactions: 12 transactions Weighted-average sale price: $399.3403 per share +2 more

5 metrics

Common shares sold 1,500 shares By Caraluna 1 Trust and Caraluna 2 Trust on October 16, 2026

Reported sale transactions 12 transactions October 16, 2026

Weighted-average sale price $399.3403 per share 215 shares sold by Caraluna 1 Trust on October 16, 2026

Weighted-average sale price $401.2871 per share 280 shares sold by Caraluna 1 Trust on October 16, 2026

Direct common shares listed following transactions 221,314 shares October 16, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average price, beneficial ownership

3 terms

Rule 10b5-1 trading plan regulatory

"pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The reported price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership over such securities."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NTRA shares did Sheena Jonathan's trusts sell?

Caraluna 1 Trust and Caraluna 2 Trust sold 1,500 Natera common shares in 12 transactions on October 16, 2026. The sales were made under a Rule 10b5-1 trading plan adopted by director and co-founder Sheena Jonathan on June 11, 2026. The shares were held for trust beneficiaries, and Jonathan disclaims beneficial ownership.

What prices were reported for the NTRA trust sales?

A 215-share sale by Caraluna 1 Trust reported a weighted average price of $399.3403 per share, within a range of $399.0150 to $399.8500. A separate 280-share sale by that trust reported a weighted average of $401.2871 per share, within a range of $400.8500 to $401.6200.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/20/2026 - 09:35 PM EDT Accepted by SEC EDGAR 10/20/2026 - 09:35 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sheena Jonathan

(Last)

(First)

(Middle)

C/O NATERA, INC.

13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)

AUSTIN

TEXAS

78753

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			CO-FOUNDER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								221,314	D
Common Stock	10/16/2026		S		215⁽¹⁾	D	$399.3403⁽²⁾	8,785	I	By Caraluna 1 Trust⁽³⁾
Common Stock	10/16/2026		S		280⁽¹⁾	D	$401.2871⁽⁴⁾	8,505	I	By Caraluna 1 Trust⁽³⁾
Common Stock	10/16/2026		S		90⁽¹⁾	D	$404.2528⁽⁵⁾	8,415	I	by Caraluna 1 Trust⁽³⁾
Common Stock	10/16/2026		S		50⁽¹⁾	D	$405.15	8,365	I	by Caraluna 1 Trust⁽³⁾
Common Stock	10/16/2026		S		35⁽¹⁾	D	$406.625	8,330	I	by Caraluna 1 Trust⁽³⁾
Common Stock	10/16/2026		S		80⁽¹⁾	D	$409.3575⁽⁶⁾	8,250	I	by Caraluna 1 Trust⁽³⁾
Common Stock	10/16/2026		S		142⁽¹⁾	D	$398.9536⁽⁷⁾	8,858	I	By Caraluna 2 Trust⁽³⁾
Common Stock	10/16/2026		S		280⁽¹⁾	D	$400.6765⁽⁸⁾	8,578	I	By Caraluna 2 Trust⁽³⁾
Common Stock	10/16/2026		S		60⁽¹⁾	D	$401.62	8,518	I	By Caraluna 2 Trust⁽³⁾
Common Stock	10/16/2026		S		90⁽¹⁾	D	$403.6972⁽⁹⁾	8,428	I	By Caraluna 2 Trust⁽³⁾
Common Stock	10/16/2026		S		80⁽¹⁾	D	$406.0563⁽¹⁰⁾	8,348	I	By Caraluna 2 Trust⁽³⁾
Common Stock	10/16/2026		S		98⁽¹⁾	D	$409.3438⁽¹¹⁾	8,250	I	By Caraluna 2 Trust⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.0150 to $399.8500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.8500 to $401.6200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.0000 to $404.4550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.0450 to $409.6700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.8050 to $399.0950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.1500 to $400.8850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.4550 to $404.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.0000 to $406.1000 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $408.7800 to $409.7700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Tami Chen, Attorney-in-Fact	10/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR